Results 231 to 240 of about 1,518,675 (340)

COVID-19 vaccine immunogenicity in Mongolian adults with and without chronic hepatitis. [PDF]

BMC Infect Dis
Callier V, Jargalsaikhan G, Batkhuu M, Ridzon R, Hunsberger S, Sereti I, Shaw-Saliba K, Weyers S, Francis A, Dashdorj N.   +9 more
europepmc   +1 more source

Considerations on COVID-19 vaccination

Clinical Immunology Communications, 2023
openaire   +4 more sources

Polyglycerol‐Based Lipids: A Next‐Generation Alternative to PEG in Lipid Nanoparticles for Advanced Drug Delivery Systems

Macromolecular Rapid Communications, EarlyView.
Linear polyglycerol is proposed as a PEG‐alternative in mRNA‐loaded lipid nanoparticles to limit activation of anti‐PEG antibodies and reduce immunogenicity. Resulting nanoparticles may provide similar gene delivery capabilities, while preventing binding of anti‐PEG antibodies compared to PEGylated counterparts.
Yara Ensminger, Rashmi Rashmi, Michael Karimov, Gideon Nölte, Markus Hafke, Ann‐Cathrin Schmitt, David Díaz‐Oviedo, Johannes Köbberling, Rainer Haag   +8 more
wiley   +1 more source

Determinants and Dynamics of COVID-19 Vaccine Hesitancy in University Students: A Machine Learning Analysis. [PDF]

Vaccines (Basel)
Torres DL, Butt ZA.
europepmc   +1 more source

Updates on COVID-19 vaccine effectiveness during Omicron [PDF]

04-COVID-Link-Gelles-508 ...

core  

Aliphatic Poly(Carbonate)s with Acid Responsive Release Mechanisms for Micellar Anti‐Tumor Drug Delivery

Macromolecular Rapid Communications, EarlyView.
Micellar systems based on biodegradable aliphatic polycarbonates and acid‐responsive triggers enhance drug solubility, stability, and tumor‐selective release. This review covers micelles with acid‐cleavable drug linkages and those that disassemble via acid‐sensitive functionalities.
Adrian V. Hauck, Lutz Nuhn
wiley   +1 more source

Effectiveness of COVID-19 Vaccine Boosters in Children Across Pandemic and Endemic Periods. [PDF]

Microorganisms
Oliveira EA, Oliveira MCL, Martelli-Júnior H, Oliveira FES, Martelli DRB, Santos R, Mak RH, Simões E Silva AC, Diniz LM, Dias CS, Foligno LRC, Herrerias RR, Andrade ALO, Barbosa IO, Colosimo EA.   +14 more
europepmc   +1 more source

Diverging Cervical Cancer Burden in Africa in the Context of WHO's Elimination Strategy: Insights From GBD 2023

Med Research, EarlyView.
The study highlights the rising cervical cancer burden in Africa, where rates have increased since 1990. Key challenges include structural health inequalities, low HPV vaccination coverage, and limited screening. Projections suggest a continued increase in incidence, deaths, and DALYs by 2038, diverging further from global trends.
Yedong Huang, Shun Chen, Shiqi Ren, Jingwei Zhao, Ziheng Wang, Zhichao Lu, Weiye Qian, Jian Wang, Ting Zhou, Yifan Wang, Zhixin Jiao, Chenyizhe Yuan, Yucheng Hou, Dong Liu, Zhining Liu, Aimin Xu, Li Liu, Qiaojun Hong, Lin Zhang   +18 more
wiley   +1 more source

Integrating Genomic Data into Test-negative Designs for Estimating Lineage-specific COVID-19 Vaccine Effectiveness. [PDF]

Clin Infect Dis
Ma KC, Surie D, Dean NE, Paden CR, Thornburg NJ, Dawood FS.   +5 more
europepmc   +1 more source

Plasmepsins as Antimalarial Drug Targets—Then, Now, and the Future

Medicinal Research Reviews, EarlyView.
ABSTRACT Malaria is a devastating disease caused by Plasmodium parasites. Plasmodium parasites express ten cathepsin D‐like aspartyl proteases, called plasmepsins (PMs). These PMs have diverse roles fulfill diverse functions throughout the parasite's lifecycle, though several exhibit functional redundancies. Among them, PMV, PMIV, and PMX are essential
Brad E. Sleebs
wiley   +1 more source